9,784 results on '"Gressner, Axel"'
Search Results
202. Disruption of TGF-beta signal transduction in hepatocellular carcinoma by overexpression of Smad7
203. Roles of TGF-beta in hepatic fibrosis
204. Isolation and Culture of Hepatic Stellate Cells.
205. LIM-domain protein cysteine- and glycine-rich protein 2 (CRP2) is a novel marker of hepatic stellate cells and binding partner of the protein inhibitor of activated STAT1
206. An unusual melting curve profile in LightCycler multiplex genotyping of the hemochromatosis H63D/C282Y gene mutations
207. Transforming growth factor β signal transduction in hepatic stellate cells via Smad2/3 phosphorylation, a pathway that is abrogated during in vitro progression to myofibroblasts
208. Expression of Smads during in Vitro Transdifferentiation of Hepatic Stellate Cells to Myofibroblasts
209. Evaluation of a New, Rapid Bedside Test for Quantitative Determination of B-Type Natriuretic Peptide
210. Lower Cardiac Troponin T and I Results in Heparin-Plasma Than in Serum
211. Participation of Smad2, Smad3, and Smad4 in Transforming Growth Factor β (TGF-β)-induced Activation of Smad7
212. The Cysteine- and Glycine-Rich LIM Domain Protein CRP2 Specifically Interacts with a Novel Human Protein (CRP2BP)
213. Modulation of transforming growth factorβ response and signaling during transdifferentiation of rat hepatic stellate cells to myofibroblasts
214. Genomic locus and promoter region of rat Smad7, an important antagonist of TGFβ signaling
215. Rapid Genotyping of Hemochromatosis Gene Mutations on the LightCycler with Fluorescent Hybridization Probes
216. Molecular and functional aspects of latent transforming growth factor-β binding protein: just a masking protein?
217. Subcellular localization of (latent) transforming growth factor β and the latent TGF-β binding protein in rat hepatocytes and hepatic stellate cells
218. De novo expression of glutamine synthetase during transformation of hepatic stellate cells into myofibroblast-like cells
219. Transformation-dependent susceptibility of rat hepatic stellate cells to apoptosis induced by soluble fas ligand
220. Analysis of the expression pattern of the latent transforming growth factor ? binding protein isoforms in normal and diseased human liver reveals a new splice variant missing the proteinase-sensitive hinge region
221. The cell biology of liver fibrogenesis - an imbalance of proliferation, growth arrest and apoptosis of myofibroblasts
222. (Latent) transforming growth factor ? in liver parenchymal cells, its injury-dependent release, and paracrine effects on rat hepatic stellate cells
223. Isoforms and splice variant of transforming growth factor β–binding protein in rat hepatic stellate cells
224. Validation by isoelectric focusing of the anion-exchange isotransferrin fractionation step involved in determination of carbohydrate-deficient transferrin by the CDTect assay
225. Immunological measurement of transforming growth factor-beta 1 (TGF-β1) in blood; assay development and comparison
226. Attenuation of TGF-β-Induced Apoptosis in Primary Cultures of Hepatocytes by Calpain Inhibitors
227. Increased serum concentration of carbohydrate-deficient transferrin in patients with combined pancreas and kidney transplantation
228. Characterization of Insulin-Like Growth Factor (IGF)-I-Receptor Binding Sites during In Vitro Transformation of Rat Hepatic Stellate Cells to Myofibroblasts
229. Molecular dissection of the mitogenic effect of hepatocytes on cultured hepatic stellate cells
230. Spatial and temporal patterns of gene expression for the proteoglycans biglycan and decorin and for transforming growth factor-β1 revealed byin situ hybridization during experimentally induced liver fibrosis in the rat
231. The response of rat liver perisinusoidal lipocytes to polypeptide growth regulator changes with their transdifferentiation into myofibroblast-like cells in culture
232. Synergism between hepatocytes and Kupffer cells in the activation of fat storing cells (perisinusoidal lipocytes)
233. Identification and partial characterization of a hepatocyte-derived factor promoting proliferation of cultured fat-storing cells (parasinusoidal lipocytes)
234. Biglycan and decorin gene expression in normal and fibrotic rat liver: Cellular localization and regulatory factors
235. Proliferation and transformation of cultured liver fat-storing cells (perisinusoidal lipocytes) under conditions of β-d-xyloside-induced abrogation of proteoglycan synthesis
236. Questioning the reliability of p-nitrophenyl-β- d-xyloside as probe to study the metabolic effects of abrogated proteoglycan synthesis in cultured cells
237. Identification of paraxanthine as the most potent caffeine-derived inhibitor of connective tissue growth factor expression in liver parenchymal cells.
238. Elevated concentrations of 15-deoxy-Δ12,14-prostaglandin J2 in chronic liver disease propose therapeutic trials with peroxisome proliferator activated receptor γ-inducing drugs.
239. Altered factor VII activating protease expression in murine hepatic fibrosis and its influence on hepatic stellate cells.
240. Bidirectional effects of Kupffer cells on hepatocyte proliferation in vitro
241. Evaluation of the kodak ektachem slide assays for iron and lactate
242. Pharmacokinetic Studies of Hematoporphyrin Derivatives on Rat Hepatocytes. Protoporphyrin Dimethyl Ester Hematoporphyrin Ether versus Dihematoporphyrin Ether-Free Hematoporphyrin Derivative
243. Logistic-regression model for assessing portal hypertension by measuring hyaluronic acid (hyaluronan) and laminin in serum
244. Activation of TGF-β within cultured hepatocytes and in liver injury leads to intracrine signaling with expression of connective tissue growth factor.
245. Intracrine signalling of activin A in hepatocytes upregulates connective tissue growth factor (CTGF/CCN2) expression.
246. Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases.
247. Changing the pathogenetic roadmap of liver fibrosis? Where did it start; where will it go?
248. Maternal factor V Leiden mutation is associated with HELLP syndrome in Caucasian women.
249. Alternative antibody for the detection of CA15-3 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access® BR Monitor assay on the UniCel® DxI 800 Immunoassay System
250. Alternative antibody for the detection of CA19-9 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access® GI Monitor assay on the UniCel® DxI 800 Immunoassay System
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.